The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients

The cardiac safety of cetuximab, particularly as single approach, has not been investigated extensively. This trial was designed to evaluate the cardiac safety of cetuximab as salvage monotherapy in Chinese chemotherapy-refractory metastatic colorectal cancer (mCRC) patients. Cetuximab was administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xue-Miao, Chen, Hao, Liu, Yu, Huang, Bin-Lian, Zhang, Xiu-Quan, Yuan, Jian-Mei, He, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279106/
https://www.ncbi.nlm.nih.gov/pubmed/28099361
http://dx.doi.org/10.1097/MD.0000000000005946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279106/
https://www.ncbi.nlm.nih.gov/pubmed/28099361
http://dx.doi.org/10.1097/MD.0000000000005946

Ejemplares similares